Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/116238
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Optometry-
dc.contributorResearch Centre for SHARP Vision-
dc.creatorZeng, X-
dc.creatorChen, R-
dc.creatorZhang, X-
dc.creatorSu, T-
dc.creatorWang, Y-
dc.creatorHu, Y-
dc.creatorShang, X-
dc.creatorShi, D-
dc.creatorYu, H-
dc.date.accessioned2025-12-03T02:54:43Z-
dc.date.available2025-12-03T02:54:43Z-
dc.identifier.issn0007-1161-
dc.identifier.urihttp://hdl.handle.net/10397/116238-
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.rights© Author(s) (or their employer(s)) 2025. No commercial re-use. See rights and permissions. Published by BMJ Group.en_US
dc.rightsThis article has been accepted for publication in British Journal of Ophthalmology, 2025 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/bjo-2024-326184. For the avoidance of doubt, this manuscript version is protected by copyright, including for uses related to text and data mining, AI training, and similar technologies.en_US
dc.titleAssociations between a healthy lifestyle score and retinal neurovascular healthen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage858-
dc.identifier.epage867-
dc.identifier.volume109-
dc.identifier.issue8-
dc.identifier.doi10.1136/bjo-2024-326184-
dcterms.abstractAims To investigate the associations between a healthy lifestyle score and retinal neurovascular health, and explore whether lower inflammation levels mediate these associations.-
dcterms.abstractMethods This study is based on the UK Biobank. The healthy lifestyle score ranged from 0 to 6 and comprised physical activity, diet, sleep duration, smoking status, alcohol consumption and bodyweight. Outcomes included retinal diseases (age-related macular degeneration (AMD) and retinal vascular occlusion (RVO)) from hospital admission records (378 648 participants), retinal vascular metrics from retinal photography (32 226 participants) and retinal neural metrics from optical coherence tomography (42 557 participants). An INFLA-score was used to characterise inflammation levels.-
dcterms.abstractResults Participants with better healthy life score (scored from 5 to 6) were associated with a 29% lower risk of AMD, 25% lower risk of RVO, 2% increase in artery-to-vein ratio (AVR), 0.22 μm increase in central retinal artery equivalent, 0.36 μm decrease in central retinal vein equivalent (CRVE), 0.004 increase in fractal dimension, 0.38 μm increase in retinal nerve fibre layer, 0.69 μm increase in ganglion cell-inner plexiform layer (GCIPL) and 0.35 μm increase in photoreceptor segment (PS) compared with those with worst lifestyle score (scored from 0 to 1) (all p trend <0.01). In addition, INFLA-score partially mediated the associations between healthy lifestyle score and increased risk of AMD (mediated proportion (MP): 14.8%), higher AVR (MP: 12.76%), narrower CRVE (MP: 24.49%), thicker GCIPL (MP: 4.97%) and thicker PS (MP: 26.86%).-
dcterms.abstractConclusion Great adherence to a healthier lifestyle was associated with better retinal health in a dose-response manner. Lower inflammation partially mediated the association between a healthy lifestyle score and retinal health.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationBritish journal of ophthalmology, Aug. 2025, v. 109, no. 8, p. 858-867-
dcterms.isPartOfBritish journal of ophthalmology-
dcterms.issued2025-08-
dc.identifier.scopus2-s2.0-85218045642-
dc.identifier.pmid39929700-
dc.identifier.eissn1468-2079-
dc.description.validate202512 bcch-
dc.description.oaAccepted Manuscripten_US
dc.identifier.SubFormIDG000434/2025-11en_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextThe present work was supported by the following fundings: National Natural Science Foundation of China (U24A20707, 82171075, 82301260), Science and Technology Program of Guangzhou (20220610092), Basic and Applied Basic Research Foundation of Guangdong Province (2023B1515120028), Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients with Persistent Diabetic Macular Edema (BEST) (2024\u201329), the launch fund of Guangdong Provincial People\u2019s Hospital for NSFC (8217040546, 8220040257), and China Scholarship Council (202308440506). The sponsor or funding organisation had no role in the study design, data collection, data analysis, data interpretation or writing the report of this study.en_US
dc.description.pubStatusPublisheden_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
Zeng_Associations_Between_Healthy.pdfPre-Published version1 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Final Accepted Manuscript
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

SCOPUSTM   
Citations

2
Citations as of May 8, 2026

WEB OF SCIENCETM
Citations

2
Citations as of Apr 23, 2026

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.